Ballard Power Systems Inc. (BLDP)
NASDAQ: BLDP · Real-Time Price · USD
1.800
-0.050 (-2.70%)
At close: Aug 8, 2025, 4:00 PM
1.810
+0.010 (0.56%)
After-hours: Aug 8, 2025, 7:59 PM EDT
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 9 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Sell" and an average price target of $1.78, which forecasts a -1.11% decrease in the stock price over the next year. The lowest target is $1.20 and the highest is $3.00.
Price Target: $1.78 (-1.11%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 7 | 7 | 7 | 7 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Susquehanna | Susquehanna | Hold Maintains $1.3 → $2 | Hold | Maintains | $1.3 → $2 | +11.11% | Jul 21, 2025 |
| UBS | UBS | Hold Maintains $2 → $1.4 | Hold | Maintains | $2 → $1.4 | -22.22% | May 12, 2025 |
| Citigroup | Citigroup | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Apr 17, 2025 |
| Susquehanna | Susquehanna | Hold Maintains $1.4 → $1.3 | Hold | Maintains | $1.4 → $1.3 | -27.78% | Apr 14, 2025 |
| Roth MKM | Roth MKM | Hold Maintains $1.75 → $1.25 | Hold | Maintains | $1.75 → $1.25 | -30.56% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
94.64M
from 69.73M
Increased by 35.72%
Revenue Next Year
118.24M
from 94.64M
Increased by 24.94%
EPS This Year
-0.40
from -1.08
EPS Next Year
-0.37
from -0.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 103.8M | 132.9M | 199.5M | ||
| Avg | 94.6M | 118.2M | 149.0M | ||
| Low | 82.6M | 94.9M | 98.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.8% | 40.4% | 68.7% | ||
| Avg | 35.7% | 24.9% | 26.0% | ||
| Low | 18.5% | 0.2% | -17.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.34 | -0.25 | -0.21 |
| Avg | -0.40 | -0.37 | -0.28 |
| Low | -0.48 | -0.39 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.